SCHEMBL4618608

SCHEMBL4618608

COc1ccc(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.68
ALDH1A1 P00352 4/20 0.64
CA1 P00915 3/20 0.64
CA2 P00918 3/20 0.64
SMN1; SMN2 Q16637 1/20 0.61
HTT P42858 2/20 0.61
HSD17B10 Q99714 1/20 0.58
KMT2A Q03164 2/20 0.54
MAPK1 P28482 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CA12 O43570 2/20 0.53
CA9 Q16790 2/20 0.53
CA4 P22748 1/20 0.53
POLB P06746 1/20 0.52
CA6 P23280 1/20 0.51
CA5A P35218 1/20 0.51
CA7 P43166 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CA5B Q9Y2D0 1/20 0.51
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617736 0.92 ALDH1A1 (0.72) SFRP1ALDH1A1SMN1; SMN2HTTPOLB
SCHEMBL4618123 0.89 SFRP1 (0.84) SFRP1ALDH1A1CA1CA2SMN1; SMN2
SCHEMBL6102195 0.87 SFRP1 (0.65) SFRP1ALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL4618621 0.85 SFRP1 (0.84) SFRP1ALDH1A1CA1CA2HSD17B10
SCHEMBL4618982 0.84 SFRP1 (0.70) SFRP1ALDH1A1CA1CA2HSD17B10
SCHEMBL6102308 0.84 SFRP1 (0.76) SFRP1ALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL6101694 0.84 SFRP1 (0.76) SFRP1ALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL4617998 0.84 ALDH1A1 (0.70) SFRP1ALDH1A1SMN1; SMN2HTTPOLB
SCHEMBL4618403 0.84 CA1 (0.77) SFRP1ALDH1A1CA1CA2HSD17B10
SCHEMBL4619413 0.83 SFRP1 (0.66) SFRP1ALDH1A1CA1CA2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885ALDH1A1 1865/4885CA1 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.